Despite the efforts to dismantle any trace of the Biden administration elsewhere, the Trump administration intends to continue the Medicare drug price negotiation program, including the 15 drugs proposed for the second round of negotiations as one of President Joe Biden's last acts in office.
The Trump Centers for Medicare and...
As one of the last acts of President Joe Biden's term, the administration listed the prescription pharmaceuticals that would be included in the second round of the program that allows the Centers for Medicare and Medicaid Services (CMS) to negotiate what it pays for certain drugs.
The announcement was made earlier than the...
All 10 drug companies whose drugs were selected for drug price negotiation with the Medicare program have elected to participate in negotiations.
President Joe Biden made the announcement on Tuesday in an online video. The first 10 companies were announced by the Centers for Medicare and Medicaid Services (CMS) in August and gave the...
Last week, the Southern District Court of Ohio heard the first oral arguments from the U.S. Chamber of Commerce (CoC, the Chamber) and the U.S. Department of Justice (DOJ). The Chamber requested an injunction of the Medicare negotiation program before October 1, which is the deadline for companies to sign an agreement to participate in...
The Biden administration released its list of 10 drugs for direct price negotiations with manufacturers. The highly anticipated list is the most recent step in enacting a part of the Inflation Reduction Act (IRA) of 2022. The drugs listed are largely treatments related to Type 2 diabetes, blood thinning, arthritis and cancer...
The Biden administration released revised guidance for the Medicare drug price negotiation program late last week in response to the mounting lawsuits against the policy required by the Inflation Reduction Act (IRA) of 2022.
Drugmakers Merck and Bristol Myers Squibb, as well as industry representatives like the U.S. Chamber of...
The U.S. Chamber of Commerce has filed suit against the federal government, challenging the Medicare drug price negotiation program.
The lawsuit is the second of an expected many against the new program which was authorized by the Inflation Reduction Act last summer. The Chamber of Commerce, which refers to itself as the "world's...
This initial program guidance details the requirements and procedures for implementing the Medicare Drug Price Negotiation Program in 2026, the first year negotiated prices will apply.
The guidance is one of a number of steps CMS laid out in the Medicare Drug Price Negotiation Program timeline for the first year of negotiation. The...
